<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.25008.003</object-id><label>Table 1.</label><caption><p>Published studies reporting <italic>P. falciparum</italic> in Africa with deletions or no deletions of the <italic>pfhrp2</italic> gene (<xref ref-type="bibr" rid="bib9">Cheng et al., 2014</xref>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Origin</th><th>Source of samples*</th><th colspan="3">Initial evidence</th><th colspan="3">Gene deletion analysis by PCR</th><th colspan="2">Antigen analysis</th><th>Ref</th><th>Prevalence (no. of samples, year of collection)</th></tr><tr><th>Country</th><th>Area</th><th/><th>Microscopy</th><th>Quality RDT</th><th>Species PCR</th><th>pfhrp2 (exon 1 and 2)</th><th>No. single copy genes</th><th>Flanking genes</th><th>HRP ELISA</th><th>2nd quality RDT</th><th/><th/></tr></thead><tbody><tr><td>Mali</td><td>Bamako</td><td>A/S</td><td>D</td><td>ND</td><td>D</td><td>D</td><td>1</td><td>ND</td><td>ND</td><td>ND</td><td>(<xref ref-type="bibr" rid="bib19">Koita et al., 2012</xref>)</td><td>2% (480, 1996)</td></tr><tr><td align="left">DRC,Gambia, Kenya, Mozambique, Rwanda, Tanzania, Uganda</td><td/><td>S</td><td>D</td><td>ND</td><td>D</td><td>Exon 2 only</td><td>ND</td><td>ND</td><td>D</td><td>ND</td><td>(<xref ref-type="bibr" rid="bib32">Ramutton et al., 2012</xref>)</td><td>0% (77, 2&#8211;19 per country, 2005&#8211;2010)</td></tr><tr><td>Senegal</td><td>Dakar</td><td>S</td><td>D</td><td>ND</td><td>D</td><td>D</td><td>1</td><td>ND</td><td>ND</td><td>ND</td><td>(<xref ref-type="bibr" rid="bib44">Wurtz et al., 2013</xref>)</td><td>2.4% (136, 2009&#8211;2012)</td></tr><tr><td>Ghana</td><td>Accra and Cape Coast</td><td>A</td><td>D</td><td>D</td><td>D</td><td>Exon 2 only</td><td>2</td><td>ND</td><td>ND</td><td>ND</td><td>(<xref ref-type="bibr" rid="bib4">Amoah et al., 2016</xref>)</td><td>29.5% (315, 2015)</td></tr><tr><td>Zambia</td><td>Choma, South Zambia</td><td>A/S</td><td>D</td><td>D</td><td>D</td><td>D</td><td>1</td><td>ND</td><td>ND</td><td>ND</td><td>(<xref ref-type="bibr" rid="bib21">Laban et al., 2015</xref>)</td><td>20% (61, 2009&#8211;2012<sup>)&#8224;</sup></td></tr><tr><td>DRC</td><td>Country-wide</td><td>A</td><td>D</td><td>D</td><td>D</td><td>D</td><td>3</td><td>D</td><td>ND</td><td>ND</td><td>(<xref ref-type="bibr" rid="bib30">Parr et al., 2016</xref>)</td><td>6.4% (783, 2013&#8211;2014)</td></tr><tr><td>Rwanda</td><td>Busogo, Musanze, Kayonza</td><td>S</td><td>D</td><td>D</td><td>D</td><td>Exon 2 only</td><td>1</td><td>ND</td><td>ND</td><td>D</td><td>(<xref ref-type="bibr" rid="bib20">Kozycki et al., 2017</xref>)</td><td>23% (140, 2014&#8211;2015)</td></tr><tr><td>Eritrea</td><td>Anseba, Debub, Gash-Barka, Northern Red-Sea</td><td>S</td><td>D</td><td>D</td><td>D</td><td>ND</td><td>1</td><td>ND</td><td>ND</td><td>D</td><td>(<xref ref-type="bibr" rid="bib7">Berhane et al., 2017</xref>)</td><td>80% (51, 2015)</td></tr></tbody></table><table-wrap-foot><fn><p>*Source of samples: S&#160;=&#160;Symptomatic case, A&#160;=&#160;Asymptomatic case, U&#160;=&#160;not specified, D&#160;=&#160;done; ND&#160;=&#160;not done.</p><p><sup>&#8224;</sup> Authors suggested that failure to detect <italic>pfhrp</italic> gene in some samples was more likely to be the result of low parasite density rather than deletion</p></fn><fn><p>Note: Quality RDT indicates RDTs that meet the WHO RDT recommended procurement criteria based on WHO Malaria RDT Product Testing.</p></fn></table-wrap-foot></table-wrap>